To investigate the impact of the Lyn/RUVBL1 complex on CRC function, we successfully engineered a recombinant plasmid based on the px330a dCas9‐KRAB plasmid as a vector for inhibiting Lyn expression (Figure S2A,B, Supporting Information). Here, RUVBL1 is linked to colorectal carcinoma.